SPDR S&P Biotech ETF (NYSEARCA:XBI) Reaches New 12-Month High – Should You Buy?

SPDR S&P Biotech ETF (NYSEARCA:XBI) shares hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $139.88 and last traded at $139.59, with a volume of 3270123 shares traded. The stock had previously closed at $135.34.

SPDR S&P Biotech ETF Stock Up 4.7%

The firm has a market cap of $9.04 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. The company’s 50-day moving average price is $132.91 and its 200-day moving average price is $127.37.

Institutional Trading of SPDR S&P Biotech ETF

Several hedge funds have recently made changes to their positions in the business. Compound Planning Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 0.7% in the 1st quarter. Compound Planning Inc. now owns 10,889 shares of the exchange traded fund’s stock valued at $1,391,000 after buying an additional 75 shares during the period. Dynamic Wealth Strategies LLC raised its holdings in SPDR S&P Biotech ETF by 3.8% in the fourth quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock valued at $268,000 after acquiring an additional 80 shares in the last quarter. Capital Investment Advisory Services LLC raised its holdings in SPDR S&P Biotech ETF by 4.0% in the fourth quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock valued at $259,000 after acquiring an additional 81 shares in the last quarter. PeakShares LLC raised its holdings in SPDR S&P Biotech ETF by 5.3% in the first quarter. PeakShares LLC now owns 1,684 shares of the exchange traded fund’s stock valued at $215,000 after acquiring an additional 84 shares in the last quarter. Finally, Commerce Bank raised its holdings in SPDR S&P Biotech ETF by 2.8% in the fourth quarter. Commerce Bank now owns 3,260 shares of the exchange traded fund’s stock valued at $397,000 after acquiring an additional 90 shares in the last quarter.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.